Exploring Hybrid Nanoparticles for Crizotinib Delivery in Lung Cancer Treatment; Design, Optimization, In-vitro and Cell Line Evaluation
Crossref DOI link: https://doi.org/10.1007/s12247-026-10431-2
Published Online: 2026-02-14
Published Print: 2026-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rahangdale, Mrunal
Patel, Ami
Dabke, Amit
Vankani, Ankit
Sawant, Krutika
Text and Data Mining valid from 2026-02-14
Version of Record valid from 2026-02-14
Article History
Received: 16 October 2025
Accepted: 27 January 2026
First Online: 14 February 2026
Declarations
:
: The authors declare no competing interests.